Central Venous Catheters Market to Reach US$4.71Bn by 2033 at 5.1% CAGR | North America Leads with 42.57% Share as ICU Expansion, Oncology Ports & Antimicrobial CVC Innovations Accelerate Adoption

The central venous catheters market size reached US$3.03Billion in 2024 from US$2.89Billionin 2023 and is expected to reach US$ 4.71Billion by 2033, growing at a CAGR of 5.1% from 2025 to 2033.
Market growth is fueled by rising ICU admissions exceeding 5 million annually in the US alone, increasing prevalence of chronic diseases like cancer and end-stage renal disease (over 800,000 patients in US), and advancements in antimicrobial-coated catheters to mitigate CRBSI risks. Key drivers include expanding outpatient infusion therapies, ICU expansions in emerging markets like India and China, and demand for long-term access via implantable ports in oncology. Additionally, regulatory emphasis on infection control and innovations in power-injectable ports for imaging compatibility continue to propel adoption in critical care and dialysis settings.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-
https://www.datamintelligence.com/download-sample/central-venous-catheters-market?sindhuri

United States: Key Industry Developments
✅ September 2025: Teleflex Incorporated expanded its Arrowg+ard Blue antimicrobial non-tunneled CVC line in US hospitals, integrating with ICU monitoring systems across 300 facilities in the Midwest to reduce infection rates by 25%.
✅ June 2025: BD launched enhanced PowerPort implantable ports with RFID tracking in California cancer centers, supporting over 100,000 chemotherapy sessions annually amid rising oncology demands.
✅ March 2025: ICU Medical introduced next-gen Port-A-Cath systems in New York dialysis clinics, featuring improved heparin coatings for thrombosis prevention in high-volume ESRD patients.

Asia Pacific / China: Key Industry Developments
✅ October 2025: B. Braun SE deployed its Certofix acute CVCs in Shanghai's major hospitals, scaling production for 500,000 units to address sepsis management in expanding ICUs.
✅ July 2025: AngioDynamics rolled out SmartPort implantable ports in Beijing oncology hubs, targeting 200,000 cancer patients with high-pressure injection capabilities for CT contrast.

Key Merges and Acquisitions :
✅ Teleflex Incorporated and Merit Medical Systems - signed a USD 250 million MOU in August 2025 for joint development of dialysis CVCs in North America, gaining exclusive antimicrobial tech and a new facility in Utah.
✅ BD - acquired a 30% stake in an Indian CVC startup in May 2025 for USD 150 million, focusing on cost-effective tunneled catheters for renal care with pilots in Mumbai hospitals.
✅ Cook Medical - formed a strategic alliance with Vygon Group in November 2025 valued at USD 100 million, merging distribution for PICCs in Europe and Asia to enhance pediatric applications.

Market Segmentation Analysis:
-By Product Type: Non-Tunneled Central Venous Catheters Lead with Dominant ShareNon-Tunneled CVCs hold 39.03% market share as of 2024, driven by acute emergency access in ICUs and ORs for fluid/drug administration, with millions of insertions annually for short-term use.
This segment dominates due to rapid insertion and cost-efficiency, outpacing others in critical care volumes.Tunneled CVCs, Peripherally Inserted Central Catheters (PICCs), Implantable Ports (fastest-growing at 25.67%), and Others account for the remaining 60.97%, with ports surging in oncology for long-term therapy.

-By Application: Oncology Holds Leading Position
Oncology commands approximately 35% market share, leveraging implantable ports for chemotherapy and supportive care amid rising cancer incidences.
Critical Care follows at about 30%, utilizing non-tunneled CVCs for vasoactive drugs and monitoring; Dialysis at 20% for hemodialysis access, while Others (e.g., sepsis, nutrition) take 15%.

-By End-User: Hospitals Maintain Dominant Share
Hospitals capture roughly 70% market share, serving as primary sites for insertions in ICUs and oncology wards.Specialty Clinics and Ambulatory Surgical Centers follow at 20% and 10%, driven by outpatient shifts.

Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=central-venous-catheters-market?sindhuri
(Purchase 2 or more Reports and get 50% Discount)

Growth Drivers:
-Expansion of critical care infrastructure, with global ICU beds growing 5-7% annually to handle trauma, sepsis, and post-surgical needs in aging populations.
-Rising chronic disease burden, including cancer (20 million new cases yearly) and CKD, increasing long-term CVC use for chemotherapy and dialysis.
-Antimicrobial and coated technologies reducing CRBSIs by 40-50%, supported by FDA approvals and hospital protocols for patient safety.
-Shift to home-based and outpatient therapies, cutting hospital stays by 20% and boosting PICCs/tunneled CVCs in developed markets.
-Economic investments in emerging Asia Pacific healthcare, creating 1 million+ jobs in medical device manufacturing and addressing 50% global dialysis needs.

Regional Insights:
-North America leads the central venous catheters market with the highest regional share, capturing approximately 42.57% of global revenue in 2024-2025, driven by high ICU admissions, advanced oncology care, and reimbursement policies in the US and Canada. This dominance stems from key players like BD and Teleflex, extensive R&D, and high procedure volumes, positioning the region as the premium market leader.

-Asia Pacific follows with the fastest growth at 5.7% CAGR and around 20% share, bolstered by urbanization, chronic disease surges in China and India, and ICU expansions. China contributes over 40% regionally through affordable adoptions and government health initiatives.
-Europe trails with 25% share, steady via aging demographics and standards in Germany/UK; Latin America and MEA add 8% and 5%, tapping potentials in Brazil's dialysis and Africa's trauma care.

Speak to Our Analyst and Get Customization in the report as per your requirements:
https://www.datamintelligence.com/customize/central-venous-catheters-market?sindhuri

Key Players:
BD | Teleflex Incorporated | B. Braun SE | Cook Medical | AngioDynamics | ICU Medical, Inc. | Merit Medical Systems | Vygon Group
Key Highlights (Top 5 Key Players) for Central Venous Catheters Market:
-BD reported approximately USD 1.2 billion in vascular access revenue for fiscal year 2025, commanding 25% market share with PowerPort innovations, including 10% growth in US oncology ports.
-Teleflex Incorporated generated estimated revenues of USD 900 million in 2024-2025 from CVC segments, holding 18% share via Arrowg+ard antimicrobial lines for critical care.
-B. Braun SE achieved USD 700 million in revenues for FY 2025, driven by 15% share in Certofix acute CVCs, with expansions in European and Asian ICUs.
-AngioDynamics recorded USD 500 million in revenues for 2025, bolstering 12% share through SmartPort for high-pressure applications.
-ICU Medical, Inc. posted over USD 400 million in CVC-focused revenue for 2025, with 10% share from Port-A-Cath systems in dialysis and oncology.

Unlock 360° Market Intelligence with DataM Subscription Services:
https://www.datamintelligence.com/reports-subscription?sindhuri

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?sindhuri

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.